Andrew Mok
Stock Analyst at Barclays
(3.70)
# 777
Out of 5,090 analysts
244
Total ratings
58.28%
Success rate
3.98%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Equal-Weight | $17 → $14 | $15.47 | -9.50% | 19 | Dec 4, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $245 → $234 | $257.85 | -9.25% | 14 | Nov 25, 2025 | |
| ASTH Astrana Health | Maintains: Equal-Weight | $36 → $26 | $22.07 | +17.81% | 2 | Nov 24, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $229 → $240 | $210.00 | +14.29% | 16 | Nov 21, 2025 | |
| SGRY Surgery Partners | Maintains: Equal-Weight | $24 → $18 | $17.19 | +4.71% | 5 | Nov 21, 2025 | |
| RDNT RadNet | Maintains: Overweight | $79 → $86 | $78.59 | +9.43% | 9 | Nov 13, 2025 | |
| BKD Brookdale Senior Living | Upgrades: Overweight | $9.5 → $14 | $10.78 | +29.87% | 1 | Nov 11, 2025 | |
| PRVA Privia Health Group | Maintains: Equal-Weight | $22 → $23 | $23.84 | -3.52% | 10 | Nov 10, 2025 | |
| OSCR Oscar Health | Maintains: Underweight | $11 → $13 | $16.77 | -22.48% | 3 | Nov 10, 2025 | |
| AGL agilon health | Maintains: Underweight | $1.5 → $1 | $0.65 | +53.33% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $35 → $44 | $38.34 | +14.76% | 12 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $111 → $117 | $113.19 | +3.37% | 4 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $383 → $300 | $265.44 | +13.02% | 9 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $18 | $19.55 | -7.93% | 6 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $141 → $150 | $112.50 | +33.33% | 18 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $149 → $143 | $117.39 | +21.82% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $250 → $263 | $231.08 | +13.81% | 25 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $495 → $525 | $486.70 | +7.87% | 15 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $185 → $144 | $151.86 | -5.18% | 10 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $395 → $385 | $330.75 | +16.40% | 14 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $352 → $386 | $330.91 | +16.65% | 13 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $87 | $75.63 | +15.03% | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5.5 → $9.5 | $9.31 | +2.04% | 2 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $4 → $3.5 | $3.57 | -1.96% | 7 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $9.33 | +28.62% | 1 | Dec 8, 2022 |
Acadia Healthcare Company
Dec 4, 2025
Maintains: Equal-Weight
Price Target: $17 → $14
Current: $15.47
Upside: -9.50%
Humana
Nov 25, 2025
Maintains: Equal-Weight
Price Target: $245 → $234
Current: $257.85
Upside: -9.25%
Astrana Health
Nov 24, 2025
Maintains: Equal-Weight
Price Target: $36 → $26
Current: $22.07
Upside: +17.81%
Tenet Healthcare
Nov 21, 2025
Maintains: Overweight
Price Target: $229 → $240
Current: $210.00
Upside: +14.29%
Surgery Partners
Nov 21, 2025
Maintains: Equal-Weight
Price Target: $24 → $18
Current: $17.19
Upside: +4.71%
RadNet
Nov 13, 2025
Maintains: Overweight
Price Target: $79 → $86
Current: $78.59
Upside: +9.43%
Brookdale Senior Living
Nov 11, 2025
Upgrades: Overweight
Price Target: $9.5 → $14
Current: $10.78
Upside: +29.87%
Privia Health Group
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $22 → $23
Current: $23.84
Upside: -3.52%
Oscar Health
Nov 10, 2025
Maintains: Underweight
Price Target: $11 → $13
Current: $16.77
Upside: -22.48%
agilon health
Nov 6, 2025
Maintains: Underweight
Price Target: $1.5 → $1
Current: $0.65
Upside: +53.33%
Nov 4, 2025
Maintains: Equal-Weight
Price Target: $35 → $44
Current: $38.34
Upside: +14.76%
Nov 4, 2025
Maintains: Underweight
Price Target: $111 → $117
Current: $113.19
Upside: +3.37%
Nov 3, 2025
Maintains: Overweight
Price Target: $383 → $300
Current: $265.44
Upside: +13.02%
Nov 3, 2025
Maintains: Equal-Weight
Price Target: $13 → $18
Current: $19.55
Upside: -7.93%
Oct 30, 2025
Maintains: Overweight
Price Target: $141 → $150
Current: $112.50
Upside: +33.33%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $149 → $143
Current: $117.39
Upside: +21.82%
Oct 28, 2025
Maintains: Overweight
Price Target: $250 → $263
Current: $231.08
Upside: +13.81%
Oct 27, 2025
Maintains: Buy
Price Target: $495 → $525
Current: $486.70
Upside: +7.87%
Oct 24, 2025
Downgrades: Underweight
Price Target: $185 → $144
Current: $151.86
Upside: -5.18%
Oct 22, 2025
Maintains: Overweight
Price Target: $395 → $385
Current: $330.75
Upside: +16.40%
Oct 9, 2025
Maintains: Overweight
Price Target: $352 → $386
Current: $330.91
Upside: +16.65%
Sep 4, 2025
Maintains: Overweight
Price Target: $80 → $87
Current: $75.63
Upside: +15.03%
Aug 19, 2025
Upgrades: Overweight
Price Target: $5.5 → $9.5
Current: $9.31
Upside: +2.04%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $4 → $3.5
Current: $3.57
Upside: -1.96%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $9.33
Upside: +28.62%